Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
First Wave BioPharma’s Acquisition of ImmunogenX
R.R. Donnelley & Sons’ Acquisition of Digital Print and Marketing Businesses from Vericast
Latham & Watkins LLP represented RRD, Lowenstein Sandler represented Chatham Asset Management, LLC, the sole owner of RRD, Kirkland & Ellis advised Vericast Corp. on the...
DarioHealth’s Acquisition of Twill
Lowenstein Sandler represented Twill, Inc. in the transaction. DarioHealth Corp. (NASDAQ: DRIO) executed the acquisition of Twill, Inc., a leader in digital-led care. The combination enables Dario...
Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
Coffee Holding Co’s Merger With Delta Corp Holdings Ltd.
Lowenstein represented Coffee Holding Co, Inc. in the transaction. The U.S.-based wholesale coffee roaster and dealer Coffee Holding Co, Inc. announced its definitive merger and share exchange...
LTS Lohmann Therapy Systems’ Acquisition of Tapemark
Lowenstein Sandler represented LTS Lohmann Therapy Systems, Corp. in the transaction. LTS Lohmann Therapy Systems, Corp. (“LTS”) executed its acquisition of Tapemark Inc. (“Tapemark”) located in...